Good afternoon, and welcome to PennyMac Mortgage Investment Trust's Fourth Quarter 2025 Earnings Call. Additional materials, including the presentation slides that will be referred to in the call are ...

What Berkshire Innovation Center is now working toward represents the next stage of its evolution: a technology hub focused ...

In recent months, a particular word has begun to circulate with striking insistence in press releases across the United ...

Buddy Punch reports that leaders are increasingly bogged down by digital tool fatigue, sacrificing key leadership work for tool management.

These imaginary battles—waged by students in James J. Ferris High School’s wildly popular Dungeons & Dragons club—are part of ...

The Motley Fool reports on the 25 best U.S. retirement locations for 2026, ranked based on retirees' priorities like quality ...

BRUSSELS (AP) — Threats from the White House over Greenland have sparked outrage and a flurry of diplomatic activity across Europe, as leaders consider possible countermeasures, including retaliatory ...

December saw our residents enjoying the second annual tree-lighting ceremony, complete with hot cocoa and activities for the kids, taking a ride to see the beautiful Christmas lights in the Beech ...

Capital market activity is rebounding as favorable market conditions encourage IPOs and M&A. The total deal value of mergers and acquisitions has surged, driven by major transactions, divestitures, ...

Healthcare deal activity cooled off in 2025, but the sector is poised to bounce back next year, driven by investments in artificial intelligence, an improved exit environment and policy shifts driving ...

Representatives from the Lazydays Employee Foundation present a final $300,000 donation to A Kid’s Place. A partnership built on compassion, commitment and community reached a milestone this week as A ...

Life sciences dealmaking came back in 2025, and artificial intelligence is poised to drive even more M&A activity in 2026 as companies move from hyping the technology to proving its value in drug ...